|
JPS5638578B2
(enExample)
*
|
1973-05-18 |
1981-09-08 |
|
|
|
CH642665A5
(en)
|
1979-02-08 |
1984-04-30 |
Rudolf Berchtold |
Process for the preparation of 1-(omega-carboxyalkyl)-2-alkyl- glycero-3-phosphatides
|
|
US4329302A
(en)
|
1980-06-27 |
1982-05-11 |
Board Of Regents, The University Of Texas System |
Synthetic phosphoglycerides possessing platelet activating properties
|
|
DE3307925A1
(de)
|
1983-03-05 |
1984-09-06 |
A. Nattermann & Cie GmbH, 5000 Köln |
Neue 0-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
|
|
US4614796A
(en)
|
1983-03-25 |
1986-09-30 |
Nippon Shinyaku Co., Ltd. |
Liposome and method of manufacture therefor
|
|
JPS6041652A
(ja)
*
|
1983-08-13 |
1985-03-05 |
Morinaga Milk Ind Co Ltd |
Ν−カルボベンジルオキシ−Ｌ−グルタミン酸−γ−コリンエステル塩の製造法
|
|
JPS60100544A
(ja)
|
1983-11-08 |
1985-06-04 |
Ono Pharmaceut Co Ltd |
新規なグリセリン誘導体，その製造方法及びその誘導体を含有する薬剤
|
|
JPS60104066A
(ja)
|
1983-11-10 |
1985-06-08 |
Ono Pharmaceut Co Ltd |
グリセリン誘導体
|
|
AT383130B
(de)
|
1984-05-15 |
1987-05-25 |
Chemie Linz Ag |
Verfahren zur herstellung von an c1 und c2 verschieden substituierten phosphatidylcholinen und phosphatidylethanolaminen ueber die neuen verbindungen 1-0-tritylglycerophosphocholin beziehungsweise (1-0,n-ditrityl)-glycerophosphoethanolamin
|
|
US4710579A
(en)
|
1984-11-09 |
1987-12-01 |
Takeda Chemical Industries, Ltd. |
2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof
|
|
JPH0617307B2
(ja)
|
1984-11-09 |
1994-03-09 |
武田薬品工業株式会社 |
抗腫瘍剤
|
|
US4827011A
(en)
|
1984-12-10 |
1989-05-02 |
American Cyanamid Company |
Antihypertensive phosphate derivatives
|
|
JPS61246196A
(ja)
*
|
1985-04-22 |
1986-11-01 |
Fuji Kagaku Kogyo Kk |
５′−０−アシル−５−フルオロウリジン及びその製造方法
|
|
EP0225129B1
(en)
|
1985-11-29 |
1989-05-24 |
Takeda Chemical Industries, Ltd. |
Phospholipid derivatives, their production and use
|
|
EP0299965A4
(en)
|
1986-03-24 |
1992-12-16 |
University Of Sydney |
Antigenic analogues of platelet activating factor (paf)
|
|
DE3777175D1
(de)
*
|
1986-04-07 |
1992-04-09 |
Upjohn Co |
Anthelmintische quaternaere alkyl-acyl-hydrazone, verfahren zur verwendung und zusammensetzungen.
|
|
JPS6294A
(ja)
|
1986-05-09 |
1987-01-06 |
Toyama Chem Co Ltd |
新規なグリセロリン酸誘導体およびその塩並びにそれらの製造法
|
|
JPS6354386A
(ja)
|
1986-08-26 |
1988-03-08 |
Takeda Chem Ind Ltd |
リン脂質およびその用途
|
|
JPS63190859A
(ja)
*
|
1986-09-18 |
1988-08-08 |
Takeda Chem Ind Ltd |
グリセリン誘導体
|
|
JPS63135395A
(ja)
|
1986-11-28 |
1988-06-07 |
Nippon Oil & Fats Co Ltd |
リン脂質誘導体及びその製造方法
|
|
JPS63188692A
(ja)
*
|
1987-01-29 |
1988-08-04 |
Nippon Oil & Fats Co Ltd |
リン脂質誘導体の製造方法
|
|
DE3807123A1
(de)
|
1988-03-04 |
1989-09-14 |
Boehringer Mannheim Gmbh |
Substrate fuer phospholipasen
|
|
JPH01258691A
(ja)
|
1988-04-06 |
1989-10-16 |
Nippon Oil & Fats Co Ltd |
リン脂質誘導体及びその製造方法
|
|
JP2534894B2
(ja)
|
1988-06-24 |
1996-09-18 |
日本ケミファ株式会社 |
新規なグリセリン誘導体およびその誘導体を含有する血圧降下剤
|
|
JPH0248585A
(ja)
|
1988-08-10 |
1990-02-19 |
Nippon Oil & Fats Co Ltd |
リン脂質誘導体及びその製造方法
|
|
JPH03258740A
(ja)
|
1990-03-06 |
1991-11-19 |
Kao Corp |
液体油、その製造法及びこれを含有する化粧料
|
|
ES2019552A6
(es)
|
1990-04-11 |
1991-06-16 |
Menarini Lab |
Procedimiento para la preparacion de glicerofosfolipidos.
|
|
JP2869572B2
(ja)
|
1990-05-14 |
1999-03-10 |
和光純薬工業株式会社 |
ホスファチジルコリン誘導体の製造方法
|
|
US5561052A
(en)
|
1992-06-18 |
1996-10-01 |
Koike; Katsumasa |
Process for detecting oxidized lipids and process for forming oxidized lipids
|
|
FR2714382B1
(fr)
|
1993-12-27 |
1996-02-02 |
Roussel Uclaf |
Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques.
|
|
AU1751795A
(en)
|
1994-03-04 |
1995-09-18 |
University Of British Columbia, The |
Liposome compositions and methods for the treatment of atherosclerosis
|
|
JP3364313B2
(ja)
|
1994-03-22 |
2003-01-08 |
株式会社トクヤマ |
ポルフィリン／インジウム錯体及び陰イオン感応膜
|
|
AU3216695A
(en)
|
1994-08-29 |
1996-03-22 |
University Of North Carolina At Chapel Hill, The |
Lipid analogs for treating viral infections
|
|
JPH08208548A
(ja)
|
1995-02-01 |
1996-08-13 |
Kao Corp |
グリセリン誘導体の製造法
|
|
US5660855A
(en)
|
1995-02-10 |
1997-08-26 |
California Institute Of Technology |
Lipid constructs for targeting to vascular smooth muscle tissue
|
|
US6261597B1
(en)
|
1995-08-31 |
2001-07-17 |
Seymour J. Kurtz |
Method for treating periodontal disease
|
|
US6096291A
(en)
|
1996-12-27 |
2000-08-01 |
Biovector Therapeutics, S.A. |
Mucosal administration of substances to mammals
|
|
JP2001512135A
(ja)
*
|
1997-07-31 |
2001-08-21 |
エラン・ファーマシューティカルズ・インコーポレーテッド |
Ｖｌａ−４によって媒介された白血球接着を阻害するジペプチドおよび関連化合物
|
|
JP3781877B2
(ja)
|
1997-10-03 |
2006-05-31 |
株式会社ムック |
アスコルビン酸誘導体またはその塩、および医薬
|
|
US6376450B1
(en)
|
1998-10-23 |
2002-04-23 |
Chanchal Kumar Ghosh |
Cleaning compositions containing multiply-substituted protease variants
|
|
US6414168B1
(en)
*
|
1998-12-28 |
2002-07-02 |
Caschem, Inc. |
Epoxidation of ricinic compounds using a phase-transfer catalyst
|
|
US6348583B1
(en)
|
1999-08-30 |
2002-02-19 |
Bio-Rad Laboratories, Inc. |
Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids
|
|
ATE287700T1
(de)
|
1999-11-30 |
2005-02-15 |
Univ Arizona |
Strahlung-sensitive liposomen
|
|
WO2001075170A1
(en)
|
2000-03-31 |
2001-10-11 |
The Regents Of The University Of California |
A functional assay of high-density lipoprotein
|
|
JP2002302470A
(ja)
*
|
2000-05-15 |
2002-10-18 |
Toagosei Co Ltd |
新規な第四アンモニウム塩及びその製造方法
|
|
AU2002218461B2
(en)
*
|
2000-11-24 |
2006-09-07 |
Vascular Biogenics Ltd |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
|
US6838452B2
(en)
|
2000-11-24 |
2005-01-04 |
Vascular Biogenics Ltd. |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
|
FI20011466A0
(fi)
*
|
2001-07-04 |
2001-07-04 |
Orion Corp |
Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä, niiden valmistusmenetelmiä ja käyttö
|
|
DE10155095A1
(de)
|
2001-11-09 |
2003-05-22 |
Cognis Deutschland Gmbh |
Alkyl(en)ylglycerinethercarbonsäuren
|
|
US7807847B2
(en)
|
2004-07-09 |
2010-10-05 |
Vascular Biogenics Ltd. |
Process for the preparation of oxidized phospholipids
|
|
KR101201935B1
(ko)
*
|
2004-07-09 |
2012-11-16 |
바스큘라 바이오제닉스 리미티드 |
산화 인지질류의 개선된 제조 방법
|
|
US20060194765A1
(en)
|
2004-11-16 |
2006-08-31 |
Garcia Joe G N |
Methods and compositions using oxidized phospholipids
|
|
WO2007014001A2
(en)
|
2005-07-21 |
2007-02-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Multiplex determination of lipid specific binding moieties
|
|
US8137977B2
(en)
|
2006-04-24 |
2012-03-20 |
Children's Hospital & Research Center At Oakland |
Lipidomic approaches to determining drug response phenotypes in cardiovascular disease
|
|
US8703179B2
(en)
|
2006-05-11 |
2014-04-22 |
Kimberly-Clark Worldwide, Inc. |
Mucosal formulation
|
|
JP2008037763A
(ja)
|
2006-08-01 |
2008-02-21 |
Adeka Corp |
抗菌剤及び抗菌剤組成物
|
|
US9006217B2
(en)
|
2007-01-09 |
2015-04-14 |
Vascular Biogenics Ltd. |
High-purity phospholipids
|
|
CA2702437C
(en)
|
2007-11-28 |
2013-06-25 |
Teva Pharmaceutical Industries Ltd. |
Method of delaying the onset of clinically definite multiple sclerosis
|
|
EP2348864A4
(en)
|
2008-10-08 |
2013-07-31 |
Vascular Biogenics Ltd |
OXIDIZED THIOPHOSPHOLIPID COMPOUNDS AND USES THEREOF
|
|
MX2011004773A
(es)
|
2008-11-06 |
2011-06-21 |
Vascular Biogenics Ltd |
Compuestos de lipido oxidados y sus usos.
|
|
CA2786060A1
(en)
|
2010-01-05 |
2011-07-14 |
Vascular Biogenics Ltd. |
Treatment with vb-201
|
|
EP2750668B1
(en)
|
2011-09-01 |
2019-12-11 |
Vascular Biogenics Ltd. |
Formulations and dosage forms of oxidized phospholipids
|